SBI Securities’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.59K Buy
879
+28
+3% +$51 ﹤0.01% 2489
2025
Q1
$1.73K Buy
851
+57
+7% +$116 ﹤0.01% 2355
2024
Q4
$4.75K Buy
+794
New +$4.75K ﹤0.01% 1940